Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

3D imaging effectively tracks skin changes in vitiligo treatment.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

The enzyme Dgat1 is essential for healthy hair and skin by controlling retinoid levels.

Tofacitinib might be used to treat hair loss.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

Oral itraconazole effectively reaches and treats deep skin layers in guinea pigs.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

The formulated gel is a promising treatment for alopecia areata.

The gel and tonic were not stable.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

GIANT improves brain imaging by using genetics to better map brain regions.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Human and mouse TGase3 enzymes are similar but differ near the activation site, crucial for their function in skin and hair development.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The gel with apigenin and celery juice promotes hair growth without causing skin irritation.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

0.5% TPGS boosts hair growth with minoxidil, but 2% TPGS increases minoxidil absorption.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

C3G and Vitisin A may help prevent hair loss by blocking male hormones and stopping hair cell death.